Initial STP705 Phase I Trial Results Show Fat Reduction
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
The expanded collaboration introduces preferred merchant rates for AmSpa’s members through Synchrony’s CareCredit credit card, offering AmSpa members savings when processing patient, customer, and client cardholder payments.